Clinical Trial Update: A Study to Identify and Characterise Patients With Chronic Kidney Disease and Proteinuria

View source ↗

Summary

AstraZeneca-sponsored clinical study that completed its objectives to identify and characterize patients with chronic kidney disease and proteinuria.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: AstraZeneca | Conditions: Renal Disease | Status: COMPLETED